Literature DB >> 9199253

Molecular cloning of cDNAs for mouse low-molecular-weight and high-molecular-weight prekininogens.

M Takano1, J Kondo, K Yayama, M Otani, K Sano, H Okamoto.   

Abstract

We isolated cDNAs encoding low-molecular-weight (L-) and high-molecular-weight (H-) prekininogens from a mouse liver cDNA library using rat T-kininogen cDNA and rat H-kininogen cDNA respectively, as probes. The signal peptide, the heavy chain, and the bradykinin moiety, which are common between the two prekininogens, consist of 20, 359, and 9 amino acids, respectively, while the light chains of the L- and H-prekininogens are composed of 44 and 273 amino acids, respectively. All 19 cysteine residues present in both mouse prekininogens are located at the same positions relative to those of human origin. The light chain of H-prekininogen contains a characteristic 15-repeated His-Gly sequence and a conserved sequence for binding prekallikrein or factor XI. Northern blotting or reverse transcription-polymerase chain reaction followed by Southern blotting using mouse L- and H-kininogen cDNAs demonstrated that both L- and H-kininogens are predominantly expressed in the liver and kidney. L-Kininogen mRNA was also expressed in other tissues, such as the adrenal gland, brain, spinal cord, testis, lung, heart, and skin, while levels of H-kininogen mRNA in these tissues were too low to detect, suggesting that L-kininogen is synthesized in various tissues of mouse, while H-kininogen is exclusively synthesized in the liver and kidney. A genomic Southern blot using H-prekininogen cDNA revealed that the L- and H-prekininogen mRNAs in mouse are probably encoded by a single gene, as is the case in both human and bovine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199253     DOI: 10.1016/s0167-4781(97)00018-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Kallidin-like peptide mediates the cardioprotective effect of the ACE inhibitor captopril against ischaemic reperfusion injury of rat heart.

Authors:  Xiuxin Liu; Martina Lukasova; Radka Zubakova; Sabina Lewicka; Ulrich Hilgenfeldt
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

2.  High molecular weight kininogen activates B2 receptor signaling pathway in human vascular endothelial cells.

Authors:  Dhaval Kolte; Noah Osman; Jia Yang; Zia Shariat-Madar
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

3.  Pharmacological characterization of ligand-receptor interactions at the zebrafish bradykinin receptor.

Authors:  Torun Bromée; Jyrki P Kukkonen; Per Andersson; J Michael Conlon; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

4.  Segmental expression of the bradykinin type 2 receptor in rat efferent ducts and epididymis and its role in the regulation of aquaporin 9.

Authors:  C Belleannée; N Da Silva; W W C Shum; M Marsolais; R Laprade; D Brown; S Breton
Journal:  Biol Reprod       Date:  2008-10-01       Impact factor: 4.285

5.  Glyco-catch method: A lectin affinity technique for glycoproteomics.

Authors:  Jun Hirabayashi; Tomomi Hashidate; Ken-ichi Kasai
Journal:  J Biomol Tech       Date:  2002-12

6.  Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis.

Authors:  Sergei Merkulov; Wan-Ming Zhang; Anton A Komar; Alvin H Schmaier; Ellen Barnes; Yihua Zhou; Xincheng Lu; Takayuki Iwaki; Francis J Castellino; Guangbin Luo; Keith R McCrae
Journal:  Blood       Date:  2007-11-13       Impact factor: 22.113

7.  Bradykinin increases intracellular calcium levels in rat testis peritubular cells via the B2 receptor subtype.

Authors:  Gunther Wennemuth; Sonja Blöcher; Wolf-Bernhard Schill; Gerhard Aumüller; Thomas K Monsees
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Lack of plasma kallikrein-kinin system cascade in teleosts.

Authors:  Marty Kwok-Shing Wong; Yoshio Takei
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.